Ayurveda on Trial: A Crisis Mishandled, Reputation Shaken
|
Code : MM0096
|
Region : Asia |
||||
OR |
|||||
|
Abstract: This Case is based on the controversy of Patanjali Ayurved Ltd’s misleading claims on Coronil Kit. The product, initially introduced to the public as a cure for Corona, had the license of being only an immunity booster. This led to greater public criticism revolving around misleading advertisements attempted by the company to attract customers. The Case also covers the role of healthcare regulators in governing the distribution of such products. The Case traces the sequence of events, from the launch of the Coronil Kit by India’s health minister, leading Patanjali Ayurved Ltd. to issue a public apology for luring consumers into buying the Coronil Kit, without implicitly stating that its consumption would merely boost immunity. The Case delves into India’s competitive Ayurvedic market, Patanjali Ayurved Ltd.’s rapid growth trajectory, and how its brand loyalty, equity, and stakeholder trust was tested on its authenticity. The financial performance is also covered in this Case. This Case establishes itself as a base for discussion on multiple management domains, such as marketing and business studies, with focus on understanding implications of misleading advertisements in healthcare, role of government in overseeing the distribution of traditional medicines, challenges faced by healthcare companies in achieving aggressive growth targets, managing crisis communication and dealing with consumer perception management, thus making it suitable for courses in Marketing Management, business ethics, corporate strategy, and healthcare management. |
|
| For Case Books
Click Here >> For Case eBooks Click Here >> |
|
Pedagogical Objectives:
Keywords: Advertising, promotion, crisis management, reputation management, Patanjali-
Contents :
» Introduction
» Company Background
»Company Growth
»Ayurvedic Market in India
»The Coronil Controversy
»Way Forward
»Exhibits
Related Case Studies
- »Satyam Computers Corporate Governance Fiasco (A): Siblings Are Dearer Than Shareholders?
- »Satyam Corporate Fiasco (B): The Role of Independent Directors
- »Satyam Corporate Fiasco (C): CEO Confesses, Company Collapses
- »Satyam Computers Corporate Governance Fiasco (D): Government Intervenes, Perplexity Prevails
- »Satyam Computers Corporate Governance Fiasco (E): New CEO's Known Problems, Unknown Solutions
Recently Bought Case Studies


